LENZ Therapeutics, Inc. (LENZ) Retained Earnings (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Retained Earnings for 2 consecutive years, with -$95000.0 as the latest value for Q3 2023.
- On a quarterly basis, Retained Earnings rose 99.96% to -$95000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was -$95000.0, a 99.96% increase, with the full-year FY2022 number at -$1.0 million, changed N/A from a year prior.
- Retained Earnings was -$95000.0 for Q3 2023 at LENZ Therapeutics, up from -$271000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$95000.0 in Q3 2023 to a low of -$217.8 million in Q3 2022.